Psilocybin Access Rights: A Call to Action - Timmy Davis

The Conservative Drug Policy Reform Group (CDPRG) campaigns to upgrade psilocybin status from Schedule 1 to Schedule 2 to unlock clinical research and patient access in the UK. The strategy relies on two pillars: building public awareness through a unified message and exerting parliamentary pressure on decision-makers. Timmy Davis argues for recognizing the therapeutic potential of psilocybin as a life-saving intervention for treatment-resistant depression. He frames the current scheduling as a historic error built on political reactions rather than science. The campaign seeks to unify the broader psychedelic community under a standard language for advocacy to drive legislative change at both local and international levels.